68166 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

GlaxoSmithKline plc revenue reports

GlaxoSmithKline plc financial reports, GlaxoSmithKline plc annual revenue in 2019. When does GlaxoSmithKline plc report revenue?
Add to widgets
Added to widgets
Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2018 10 440 510 703 $ +1.14 % ↑ 1 547 544 285 $ -
30/09/2018 10 543 876 000 $ +0.35 % ↑ 1 847 654 000 $ +13.8 % ↑
30/06/2018 9 654 974 900 $ +1.24 % ↑ 582 468 390 $ -
31/03/2018 10 122 362 422 $ - 769 478 949 $ -
31/12/2017 10 322 970 289 $ - -737 837 646 $ -
30/09/2017 10 506 796 520 $ - 1 623 643 680 $ -
30/06/2017 9 536 313 000 $ - -234 499 500 $ -
Show:
to

GlaxoSmithKline plc financial report charts

GlaxoSmithKline plc quarterly report dates

31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
6 741 688 807 $ 7 109 168 000 $ 6 603 950 000 $ 6 771 134 431 $ 6 866 214 431 $ 6 954 071 240 $ 6 124 345 275 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
3 698 821 896 $ 3 434 708 000 $ 3 051 024 900 $ 3 351 227 991 $ 3 456 755 858 $ 3 552 725 280 $ 3 411 967 725 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
10 440 510 703 $ 10 543 876 000 $ 9 654 974 900 $ 10 122 362 422 $ 10 322 970 289 $ 10 506 796 520 $ 9 536 313 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
10 440 510 703 $ 10 543 876 000 $ 9 654 974 900 $ 10 122 362 422 $ 10 322 970 289 $ 10 506 796 520 $ 9 536 313 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 979 328 246 $ 2 488 730 000 $ 1 028 895 410 $ 2 339 272 069 $ 3 359 458 586 $ 2 514 504 280 $ -26 055 500 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 547 544 285 $ 1 847 654 000 $ 582 468 390 $ 769 478 949 $ -737 837 646 $ 1 623 643 680 $ -234 499 500 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 370 500 124 $ 1 287 364 000 $ 1 221 730 750 $ 1 267 047 304 $ 1 633 783 359 $ 1 402 603 080 $ 1 641 496 500 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
4 762 360 561 $ 4 620 438 000 $ 5 575 054 590 $ 4 431 862 362 $ 3 506 755 845 $ 4 439 566 960 $ 6 150 400 775 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
21 559 902 973 $ 22 695 654 000 $ 22 511 544 760 $ 23 018 493 223 $ 21 495 940 357 $ 23 652 683 840 $ 21 399 382 150 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
73 958 606 134 $ 76 361 012 000 $ 76 123 731 650 $ 78 712 510 559 $ 76 190 520 731 $ 78 748 058 120 $ 75 864 496 575 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
5 205 607 813 $ 4 673 861 000 $ 4 867 111 150 $ 5 265 814 957 $ 4 864 863 600 $ 5 822 075 440 $ 4 678 265 025 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
7 378 538 307 $ -3 781 306 000 $ 4 583 141 300 $ 4 824 310 642 $ 3 817 566 575 $ 6 349 893 600 $ 8 613 948 300 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
5 041 300 642 $ 5 046 519 000 $ 5 450 900 330 $ 5 718 532 080 $ 5 285 133 761 $ 6 463 763 000 $ 5 303 597 025 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
33 197 690 736 $ -36 106 130 000 $ 37 064 008 980 $ 24 467 748 657 $ 23 093 237 239 $ 25 498 707 760 $ 24 584 667 025 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
44.89 % - 48.69 % 31.08 % 30.31 % 32.38 % 32.41 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
5 553 327 640 $ 5 832 228 000 $ 4 859 186 410 $ -96 710 469 $ -91 891 868 $ 1 733 494 160 $ 1 056 550 525 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
5 246 366 181 $ 2 706 331 000 $ 1 798 915 980 $ 1 209 581 663 $ 3 877 026 019 $ 2 541 297 080 $ 1 313 197 200 $

Last revenue report of GlaxoSmithKline plc was 31/12/2018. According to last financial report total revenue in GlaxoSmithKline plc was 10 440 510 703 US dollar and changed by +1.14% since last year. Net income in GlaxoSmithKline plc was 1 547 544 285 $ in last quartal, net income changes to +13.8%.

GlaxoSmithKline plc stocks data

GlaxoSmithKline plc financials